To identify target genes of the Wnt/b-catenin signaling pathway in early mouse embryonic development we have established a co-culture system consisting of NIH3T3 ®broblasts expressing different Wnts as feeder layer cells and embryonic stem (ES) cells expressing a green uorescent protein (GFP) reporter gene transcriptionally regulated by the TCF/b-catenin complex. ES cells speci®cally respond to Wnt signal as monitored by GFP expression. In GFP-positive ES cells we observe expression of Brachyury. Two TCF binding sites located in a 500 bp Brachyury promoter fragment bind the LEF-1/b-catenin complex and respond speci®cally to b-catenin-dependent transactivation. From these results we conclude that Brachyury is a target gene for Wnt/b-catenin signaling. q
Introduction
Genetic analysis in Drosophila has already identi®ed the major components of the Wingless (Wg) signal transduction pathway, which determines cell fate decision during embryonic development (for review, Cadigan and Nusse, 1997; Peifer, 1997) . More recently, additional components of this pathway have been described in vertebrate cells, demonstrating that this signaling pathway is evolutionarily highly conserved and controls important cellular processes such as embryonic induction, cell fate speci®cation, and the generation of cell polarity (for review, Gumbiner, 1998; Moon and Kimelman, 1998; Gradl et al., 1999a) . Structural and functional homologues of the pathway exist throughout the animal kingdom but have been best characterized in Drosophila and vertebrates: The Wg/Wnt secreted glycoproteins bind to the Frizzled (fz) membrane receptors, which interact with dishevelled, leading to an inactivation of the shaggy/GSK3b kinase. The inactivation of the kinase results in a cytoplasmic stabilization of Armadillo/b-catenin, due to hypo-phosphorylation which enables binding of Armadillo/b-catenin to pangolin/TCF/LEF-1 transcription factors and a nuclear translocation of this protein complex that ultimately controls target gene expression. b-catenin is a pivotal component of the Wnt/Wg signaling pathway since its cytoplasmic turnover is tightly regulated (Yost et al., 1996; Aberle et al., 1997; Orford et al., 1997; Jiang and Struhl, 1998) . Degradation of b-catenin requires, besides GSK3b, multimeric protein interactions involving adenomatous polyposis coli (APC) and Axin/Conductin. b-Catenin is also a major component of the cellular adhesion machinery, since it binds to the intracellular domain of cadherins and through its association with a-catenin links cadherins to the actin cytoskeleton (Kemler, 1993; BenZe'ev and Geiger, 1998) . Thus b-catenin can form complexes with various binding partners present in different cell compartments, i.e. the plasma membrane, the cytoplasm and the nucleus. The cell has developed elaborate ways to assure the speci®c function of b-catenin in each compartment. One aspect of this regulation is inherent in the structural organization of b-catenin itself, since the key protein interactions with either E-cadherin, APC or TCF/LEF-1 are at overlapping sites and thus mutually exclusive (Hulsken et al., 1994; Rubinfeld et al., 1995; Orsulic et al., 1999) . Moreover, there appears to be a hierarchy for b-catenin in binding to these partners, with binding to E-cadherin being dominant over that to APC and TCF/LEF-1, while TCF/LEF-1 can bind to b-catenin which has escaped the APC/Axin/ GSK3b degradation machinery (Orsulic et al., 1999 ). An interaction of the cytoplasmic, stabilized b-catenin with TCF/LEF-1 and its nuclear localization is, under physiological conditions, the result of a Wnt signal. Intriguingly, the Wnt signaling cascade becomes activated in several types of tumor cells. For example the proto-oncogene Wnt-1 promotes mammary gland hyperplasia in mice (Nusse and Varmus, 1982) . Unphysiologically stabilized cytoplasmic b-catenin has been observed in colon carcinomas, due either to gain-of-function mutations in b-catenin itself or to mutations in its binding partners E-cadherin and APC Robbins et al., 1996; Korinek et al., 1997; Rubinfeld et al., 1997) . In the nucleus TCF/LEF-1 binds to speci®c nucleotide sequences and together with b-catenin confers transactivation activity, and this complex is thus believed to regulate the expression of target genes. Several potential target genes have recently been reported in development, e.g. in Drosophila ultrabithorax (Riese et al., 1997) , in Xenopus siamois (Brannon et al., 1997) , Twin (Xtwin; Laurent et al., 1997) , the secreted protein nodalrelated 3 (Xnr3; McKendry et al., 1997 ), engrailed-2 (McGrew et al., 1999 and ®bronectin (Gradl et al., 1999b) as well as in colon cancer, e.g. c-myc and cyclin D1 (He et al., 1998; Shtutman et al., 1999; Tetsu and McCormick, 1999) .
We are interested in identifying Wnt target genes during early mouse development. In a working model we had previously proposed that Wnt signaling might play an important role in the epithelial-mesenchymal transition in gastrulation stage embryos (Huber et al., 1996a) . To monitor Wnt-dependent gene expression we have exploited mouse embryonic stem (ES) cells and established a coculture system with NIH3T3 cells expressing different Wnts. Here we provide evidence that the mesoderm-speci®c gene Brachyury is regulated by the Wnt signaling pathway in ES cells. Cells were co-transfected with pTOPFLASH and control pFOPFLASH reporter constructs and b-catenin and/or LEF-1 cDNAs in combination and analyzed for luciferase activity. Transfection with lacZ cDNA was included to correct variation in transfection ef®ciencies. pTOPFLASH contains three TCF/LEF-1 binding sites driving the luciferase reporter; the inactive mutant form of this vector (pFOPFLASH) was included for a control. b-catenin already led to an induction of activity, which was further increased by the addition of LEF-1.
Results and discussion

ES cells respond to Wnt signal
In our attempts to establish a cell system appropriate for the identi®cation of Wnt-dependent target genes expressed during early mouse embryonic development we have concentrated on embryonic stem (ES) cells. We ®rst investigated whether ES cells express the relevant components required for the transduction of Wnt signal. Indeed several Wnt receptors were found to be expressed in ES cells as monitored by RT-PCR analysis, including Frizzled (fz) 3 to 9 (Fig. 1A) . These results suggested that ES cells can respond to Wnt signal when co-cultured on ®broblasts which express different Wnts. And in fact, a free cytoplasmic pool of b-catenin was observed in ES cells co-cultured on Wnt-expressing NIH3T3 ®broblasts (Fig. 1B) . For these studies, we used fusion proteins containing the glutathione-S-transferase (GST) tag and the full-length cytoplasmic domain of E-cadherin (GST-ECT.884), or, as a control, a truncated version lacking the b-catenin-binding site (GST-ECT.823) in binding assays with cell lysates from ES cells stimulated by different Wnt-expressing NIH3T3 cells. Interestingly, not all Wnts were able to induce a cytoplasmic pool of b-catenin in ES cells (Fig. 1B) . Stimulation by Wnt1, 3a and 4 resulted in a clearly detectable free cytoplasmic pool of b-catenin, while others (Wnt5a, 7b) only occasionally induced a small amount of cytoplasmic bcatenin. Among those which could induce cytoplasmic bcatenin was Wnt4, which is believed to belong to the subgroup of Wnt molecules not signaling via b-catenin. It is likely that Wnt4 uses one of the several Frizzled receptors under these experimental conditions (Fig. 1A) . It has been reported previously that ES cells express TCF3 and 4, the downstream components of the Wnt signaling pathway which are required for the nuclear function of b-catenin (Korinek et al., 1998) . To test the ability of ES cells to respond to a Wnt signal, ES cells were transiently transfected with the TCF/b-catenin-dependent luciferase reporter plasmid pTOPFLASH; pFOPLASH served as a control. These two plasmids contain promoters with three copies of an optimal or in the control a mutant version of a TCFresponse motif upstream of a minimal c-fos promoter driving luciferase expression (Korinek et al., 1997) . Transient transfection of the pTOPFLASH reporter plasmid together with a b-catenin cDNA encoding a stabilized mutant form of the protein (S33A) (Aberle et al., 1997) led to high luciferase activity which was further increased by the cotransfection of LEF-1 (Fig. 1C) . A lacZ expression construct was included in all transfection reactions so that b-galactosidase (b-gal) activity could be used to normalize luciferase activity (not shown). All these results indicated that ES cells would be suitable to study the response to Wnt signaling.
Next we tested whether ES cells respond to Wnt signals expressed by NIH3T3 ®broblasts stably transfected with different Wnt cDNAs (Kispert et al., 1998) . The expression ef®ciency of Wnts in the ®broblasts was controlled by northern blot and RT-PCR analysis (not shown). To monitor the Wnt responsiveness of ES cells under such culture conditions, a green¯uorescent protein reporter construct (pTOP-FLASH-GFP) was stably introduced into ES cells. The conceptual idea behind this approach had two aspects. First, ES cells which received a Wnt signal should express GFP and thus could be isolated by¯uorescence-activated cell sorting (FACS). Second, we assumed that in GFP-positive ES cells endogenous target genes would also be activated due to Wnt signal. As can be seen in Fig. 2 , ES cells indeed respond to Wnt signaling as monitored by GFP expression. However, ES cells did not respond to all Wnts; co-culture of ES cells on NIH3T3 cells expressing Wnt1, 3a and 4 clearly led to an expression of GFP, while co-culture on ®broblasts expressing Wnt5a, 7a, 7b and 11 had no effect on GFP expression (not shown), similar to coculture with NIH3T3 cells expressing lacZ.
These results clearly demonstrated that ES cells differentially respond to Wnt signals.
The b -catenin/LEF-1 complex binds and activates the Brachyury promoter fragment
A ®rst hint that Brachyury might be a potential target gene for Wnt signaling came from our studies with cells genetically altered for E-cadherin expression (Huber et al., 1996b) . We noticed that ES cells negative for E-cadherin (E-cad 2/2) mimic part of the Wnt signaling pathway, particularly that they expressed LEF-1 and exhibited nuclear localization of b-catenin (Huber et al., 1996b; Orsulic et al., 1999) . Moreover, E-cad 2/2 cells expressed Brachyury as shown in northern blot analysis (Larue et al., 1996) . Remarkably, re-introducing E-cadherin into Ecad 2/2 ES cells caused b-catenin to be complexed at the cell membrane, resulting in a down-regulation of both LEF-1 and Brachyury expression. These results suggested some link between the expression of LEF-1 and Brachyury and the localization of b-catenin in different cell compartments. This stimulated us to make a sequence analysis of the Brachyury promoter for potential TCF/LEF-1 binding sites matching the consensus sequence WWCAAWGG. Two potential TCF/LEF-1 binding sites were identi®ed 191 (TCF-site I) and 273 (TCF-site II) bp upstream from the transcriptional start site of Brachyury (Fig. 3A , boxed sequences). To directly assay for binding of LEF-1 and bcatenin to these sites, electrophoretic gel-mobility shift analysis was performed with recombinant LEF-1 and bcatenin produced in E. coli (Fig. 3B) . LEF-1 bound speci®-cally to the promoter fragment of Brachyury, and co-incubation with b-catenin produced a LEF-1/b-catenin complex that interacts with DNA. The size of this complex was further increased by the addition of monoclonal antib-catenin antibody. As expected, no binding of b-catenin/ LEF-1 was observed when TCF binding sites I and II in the promoter were mutated (Fig. 3B) . These experiments show that there is speci®c binding of the b-catenin/LEF-1 complex to either or both of the two TCF recognition sites in the Brachyury promoter. To demonstrate that these two TCF-sites can confer transactivation activity mediated by b-catenin, lu®cerase reporter assays were performed in ES cells. Wild-type (wt) and mutated (TCF I m and II m ) Brachyury promoter-luciferase constructs were co-transfected with the S33A b-catenin mutant (Fig. 3C) . S33A b-catenin caused a more than 10x fold increase of the reporter activity from the wild-type promoter. However, mutations in either TCF I or TCF II considerably reduced bcatenin-dependent activation. Mutations in both TCF sites at once resulted in a further reduction of b-catenin-dependent luciferase activity to almost basal level (Fig. 3C) . The addition of LEF-1 in these reporter assays gave only a marginal increase of activation (not shown), most likely due to the fact that ES cells express the TCF/LEF-1 family members TCF3 and 4 endogenously (Korinek et al., 1998) . These experiments strongly suggested that Brachyury is regulated by b-catenin/LEF-1 and may thus be a target gene of the Wnt-signaling pathway.
Wnt signal induces Brachyury expression
We next examined whether Brachyury expression can also be detected in ES cells co-cultured on Wnt-expressing feeder cells. For this, ES cells were co-cultured on Wntexpressing NIH3T3 cells for 24 h and subjected to FACS cell sorting. The GFP-positive ES cells were analyzed for Brachyury expression by RT-PCR (Fig. 4A) .
Indeed, expression of Brachyury was induced in GFPpositive ES cells by Wnt1, 3a and 4, but not by Wnt5a, 7a, 7b and 11. These results are remarkable in several respects. Most importantly, endogenous Brachyury expression can be induced in ES cells after co-culture on Wntexpressing ®broblasts. Yet, not all Wnts appear to induce Brachyury expression. It is very unlikely that Brachyury expression is due to some unspeci®c mitogenic stimulus since not all Wnts were able to induce Brachyury expression. To demonstrate unambiguously the Wnt-induced expression of Brachyury, northern blot analysis were performed on mRNA from ES cells co-cultured on either Wnt3a-or b-gal-expressing NIH3T3 cells (Fig. 4B) . Brachyury mRNA was only detected in cells exposed to Wnt3a signal. The ®nding that Brachyury expression is a direct consequence of the Wnt signaling pathway was further supported by experiments in which the pathway was activated by the stable b-catenin mutant S33A, acting downstream of Wnt. ES cells were transiently transfected with a vector coding either GFP and myc-tagged S33A-bcatenin or with a vector coding only GFP as a control. GFPpositive cells of both transfections were sorted by FACS. As can been seen in an immunoblot with anti-myc antibodies (Fig. 4C left panel) , b-catenin is only detectable in cells expressing the mutant S33A form and only in these cells was Brachyury expression detected by RT-PCR analysis (Fig. 4C, right panel) . These experiments clearly demonstrate that Brachyury is a target gene of the Wnt signaling pathway.
The Brachyury gene was originally identi®ed by positional cloning in the mouse and is the founder member of a family of transcription factors called the T-box gene family (Papaioannou and Silver, 1998; Smith, 1999) . Brachyury homologues have been isolated in various species and the expression pattern is highly conserved among different vertebrates. In the mouse, Brachyury expression starts at the onset of gastrulation. It is restricted to the nascent and migrating mesoderm, the node, the notochordal plate and the notochord (Wilkinson et al., 1990) .
The regulation of Brachyury expression has largely been studied in Xenopus and mouse. It has been shown that mesoderm-inducing signals of the ®broblast growth factor (FGF) and transforming growth factor-b (TGF-b) families can induce the expression of Xbra, the Xenopus Brachyury gene (Latinkic et al., 1997) . A 381 bp fragment 5 H of the Xbra2 transcription start site is suf®cient to confer responsiveness to FGF and activin. In analyzing different portions of the Brachyury promoter region in the mouse, it became apparent that several regulatory sequences in the promoter are required for activation of Brachyury in the primitive streak, the node, or the notochord (Clements et al., 1996) . A 500 bp promoter fragment 5 H of the mouse Brachyury transcriptional start site is suf®cient to drive the expression of the lacZ reporter gene in the primitive streak but is not suf®cient to confer expression of the transgene in the head process and notochord (Clements et al., 1996) . From these results it was concluded that the 500 bp promoter harbors the transcriptional control elements that mediate the response to mesoderm-inducing signals. We show here that the 500 bp promoter fragment is regulated by b-catenin/LEF-1 and that Wnt signaling induces expression of Brachyury. Thus, alongside the already mentioned regulation by FGF and activin, we add a new control mechanism which regulates the expression of Brachyury. It is likely that Wnt, FGF, and TGF-like signaling pathways act in concert to control Brachyury expression. Such a cooperation of different signaling pathways in regulating gene expression in development is likely to be of general importance Torres et al., 1999) . It has been reported that in Xenopus the expression of Siamois is regulated by the cooperation of the Wnt and the SMAD2 pathways (Crease et al., 1998) . Interestingly, two potential TCF binding sites can also be found in the Xenopus Xbra promoter region at comparable intervals and distances from the transcriptional start (Latinkic et al., 1997) . This similarity suggests that Wnt signaling controls Brachyury expression in Xenopus as well as in mouse.
In the mouse, among the known Wnt genes, Wnt3 is the most likely candidate to regulate Brachyury expression during early mesoderm formation. Recently it has been shown by gene targeting that Wnt3 is required for embryonic axis formation (Liu et al., 1999) . Embryos lacking Wnt3 do not form a primitive streak, mesoderm or node, and expression of Brachyury is abolished in these embryos. In later stages of development, Wnt3a must also be considered as a regulator of Brachyury expression, i.e. in the paraxial mesoderm. Experimental gene targeting of Wnt3a affects dorsal mesoderm development with a primary defect in developing somites and Brachyury expression is greatly reduced and altered (Takada et al., 1994) . A Wnt3a-like mutant phenotype was also observed in LEF-1/TCF1 double mutant embryos (Galceran et al., 1999) . From the results reported here and the gene targeting of Wnt3 and Wnt3a we propose that Wnt3 is the signaling component regulating early streak expression of Brachyury, while Wnt3a controls the expression in the paraxial mesoderm and tailbud (Galceran et al., 1999) . Although Wnt3 was not included in our ES cell co-culture experiments, its closest homologue Wnt3a can induce Brachyury expression, suggesting that ES cells may also be able to respond to Wnt3.
The ES cell co-culture system reported here seems well suited to identify more mesoderm-speci®c genes which are induced by Wnt signal. We have also observed induction of several other early mesodermal marker genes in our coculture system. These genes are currently being investigated as potential targets of Wnt signaling.
Materials and methods
Cell culture
Mouse embryonic stem (ES) cells were grown on gelatinized tissue culture dishes in 60% buffalo rat liver (BRL) cell conditioned medium (Smith and Hooper, 1987) .
NIH3T3 ®broblasts were grown in Dulbecco's modi®ed Eagle's (DMEM)-medium supplemented with 10% fetal calf serum (FCS).
For co-culturing of ES cells with NIH3T3 ®broblasts, the ®broblasts were plated 1 day before co-cultivation at a density to reach 80% con¯uence on the day of co-cultivation. The DMEM medium was replaced by BRL-medium two hours before adding the ES cells directly onto the ®bro-blasts. After 24 h of co-culturing, the cells were prepared for RT-PCR, transactivation assays, or¯ow cytometry. ES cells containing the pTOPFLASH-EGFP reporter plasmid were transfected by a modi®ed calcium phosphate precipitation method (Chen and Okayama, 1987) and selected with 500 mg/ml G418. EGFP (Enhanced Green Fluorescent Protein) expression of G418-resistant clones was tested by culturing the cells in the presence of 20 mM LiCl (Hedgepeth et al., 1997) . Expression of EGFP (referred to throughout as simply GFP) was monitored by visualizing¯uorescence under an Axioskop microscope (Zeiss, Jena).
Plasmids and constructs
The Brachyury-promoter luciferase reporter construct (pTPwt: T-Promoter in pGL3Basic) was generated by cloning a 618 bp promoter fragment of the mouse Brachyury gene, corresponding to region 2484 to 1134 of the 5 H region of Brachyury (Clements et al., 1996) , into the promoterless luciferase reporter plasmid pGl-3Basic (Promega).
Mutations of the TCF-sites were generated within the pTPuWt plasmid by PCR-based site-directed mutagenesis as described (Mikaelian and Sergeant, 1992) . For this, the following primers were used: To construct the reporter plasmid pTOPFLASH-GFP, the promoter/enhancer region of the expression vector pEGFP-N3 (Clontech) was removed by XhoI and AseI cleavage, and replaced by a SalI-fragment of the TCF-activatable plasmid pTOPFLASH, containing three TCF-binding elements in front of the c-fos minimal promoter (Korinek et al., 1997) (kindly provided by H. Clevers, Utrecht/Netherlands).
The expression vector pCS21 MMBCS33A6mt-GFP with cDNAs for both the mus musculus b-catenin mutant form S33A (Aberle et al., 1997) , C-terminally fused to six myc tags and GFP was constructed as follows: the GFP cassette of the vector pEGFP-N3, including the promoter and a polyA-signal, was removed by cleaving pEGFP-N3 with AseI and A¯II. The sites were made blunt with Klenow fragment and the cassette was inserted into pCS21 MMBCS33A6mt cleaved with NotI, after making blunt with Klenow fragment prior to ligation. The cDNA of bcatenin was C-terminally fused to six myc tags by cleaving the vector pCS21 S33A (Aberle et al., 1997) with BamHI, generating a fragment containing the whole cDNA of mutated b-catenin. This fragment was than cloned into the BamHI-cleaved pCS21 6mt. pCS21 6mt-GFP was cloned as described above, but it does not contain the cDNA for b-catenin S33A. For the reporter transactivation assays we used pCS21 S33A, in which the six myc tags were removed by cloning the BamHI b-catenin fragment of pCS21 MMBCS33A6mt into the pCS21 -vector.
Reporter assays
ES-cells were plated at a density of 4 £ 10 5 per 35 mm tissue culture dish one day before transfection. Transfection was done by calcium phosphate precipitation with 1.5 mg of the following plasmids: pCMVbGal, which was used for standardization of transfection ef®ciency and pCS21 or pCS21 S33A. b-galactosidase and luciferase assays were performed as described (Orsulic et al., 1999) on an EG&G Berthold Autolumat LB953.
All measurements were repeated ®ve times independently and luciferase activity was normalized to the b-galactosidase activity as an internal tranfection control.
Flow cytometry
GFP expression of ES cells, stably transfected with the reporter plasmid pTOPFLASH-GFP and stimulated by the co-culture system, was analyzed on a Beckton-Dickinson 
RT-PCR
Total RNA was puri®ed using the RNeasy-kit (Qiagen) following the manufacturer's instructions. Before ®rst-strand cDNA synthesis, 1 mg of total RNA was treated with DNAseI (Gibco, BRL) and reverse transcription was done with the Superscripte Preampli®cation System (Gibco BRL) using oligo(dT) as primer.
One-tenth of the cDNA was used for a semi-quantitative PCR on a Perkin Elmer 2400 thermal cycler in a reaction volume of 25 ml (cycle conditions: denaturation 958C, 30 s; annealing 558C, 30 s; extension 728C, 30 s; 28 cycles for Brachyury). For the ampli®cation of Brachyury the following primers were used:
